[Skip to Content]

Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set – (Eye Journal AOP)

21 July 2017

This news item is available to RCOphth members only, please log in below to access.

Members Login